Uruguay-based medical cannabis operator NetCann announced Wednesday a new partnership with Megalabs, one of Latin America’s leading pharmaceutical companies.
Under the agreement, Megalabs will have rights to distribute NetCann’s branded pharmaceutical products across 27 countries in Latin America.
“As a leading global pharmaceutical laboratory, the partnership between Megalabs and NetCann is a major milestone for the rapidly growing cannabis industry in Latin America. This partnership will ensure that NetCann has the capability to reach both international and Latin American markets and, as a leading GMP certified producer in the region, NetCann will continue to execute on our strategic growth plan to expand our production, reach, and patient access to the highest quality cannabis,” Gabriel Rodriguez, founder of NetCann, told Benzinga.
NetCann produces cannabis in Uruguay under the rigorous agricultural and pharmaceutical standards.
Also based in Uruguay, Megalabs boasts 17 pharmaceutical plants and 6 R&D centers in Latin America.
Encuentra nuestro contenido sobre cannabis y otros teams en Español en El Planteo:
- La Biblia de los Restaurantes: Dónde Comer en Montevideo, Uruguay
- The La Planta: Cumbia Cannábica a la Conquista del Mundo Entero
- Willie Nelson Es el Héroe que la Industria del Cannabis Necesita
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.